The Evolving Glaucoma Toolbox

Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.

By
Veronica Daub
June 17, 2026
4 min

Optometric Management

Overview

Emerging technologies and treatment strategies are enhancing glaucoma management. Key advancements include the use of 10-2 visual field testing, selective laser trabeculoplasty (SLT), and new drug-delivery systems.

Background

Glaucoma is a complex eye disease that requires effective management strategies to prevent progression and preserve vision. Traditional approaches focused primarily on lowering intraocular pressure (IOP) are evolving as new technologies and treatment paradigms emerge.

Data Highlights

No numerical data provided in the source material.

Key Findings

10-2 visual field testing can detect central defects missed by traditional 24-2 testing.
Selective laser trabeculoplasty (SLT) may allow patients to remain medication-free for years with lower progression rates.
Normal-tension glaucoma (NTG) can progress despite acceptable IOP levels; systemic and vascular risk factors should be evaluated.
Emerging technologies aim to address nocturnal IOP fluctuations, including wearable devices that lower IOP during sleep.
Minimally invasive glaucoma surgery (MIGS) may reduce medication dependence and improve quality of life.
Medication adherence is a challenge; new drug-delivery platforms are being developed to improve consistency and reduce reliance on daily drops.